bupivacaine and am-356

bupivacaine has been researched along with am-356 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S1
Furness, JB; Hunne, B; Matsuyama, H; McHugh, D; Needham, K; Nguyen, TV; Thacker, M1

Reviews

1 review(s) available for bupivacaine and am-356

ArticleYear
TASK Channels Pharmacology: New Challenges in Drug Design.
    Journal of medicinal chemistry, 2019, 11-27, Volume: 62, Issue:22

    Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain

2019

Other Studies

1 other study(ies) available for bupivacaine and am-356

ArticleYear
Evidence that TASK1 channels contribute to the background current in AH/type II neurons of the guinea-pig intestine.
    Neuroscience, 2008, Aug-26, Volume: 155, Issue:3

    Topics: Action Potentials; Anesthetics, Local; Animals; Arachidonic Acids; Bupivacaine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Gene Expression Regulation; Guinea Pigs; Hydrogen-Ion Concentration; In Vitro Techniques; Intestines; Lectins; Male; Membrane Potentials; Nerve Tissue Proteins; Neurons; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Potassium Channels, Tandem Pore Domain; Potassium Chloride; RNA, Messenger; Time Factors

2008